Continuous heparinization and circulating adhesion molecules in the critically ill

Shock

Volumn 11, Issue 1, 1999, Pages 13-18

  Boldt, Joachim ^a   Papsdorf, Michael ^b   Piper, Sven Nikolas ^b   Rothe, Alf ^b   Hempelmann, Gunter ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INJURY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

ADULT; AGED; CELL ADHESION MOLECULES; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SEPSIS; WOUNDS AND INJURIES;

EID: 0032615701     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199901000-00002     Document Type: Article

References (40)

1. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990.
2. Ley K: Leukocyte adhesion to vascular endothelium. J Reconstr Microsurg 8:495-503, 1992.
3. McEver: Leukocyte interactions mediated by selectins. Thromb Haemost 66:80-87, 1991.
4. Adams DH: Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831-836, 1994.
5. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993.
6. Newman W, Beall LD, Carson CW, et al: Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150:633-654, 1993.
7. Bouchama A, Mammami MM, Haq A, Jackson J, Al-Sedairy S: Evidence for endothelial cell activation/injury in heatstroke. Crit Care Med 24: 1173-1178, 1996.
8. Hawiger JJ: Hemostasis, bleeding, and thromboembolic complica tions of trauma and infection. In Clowes GHA Jr (ed): Trauma, sepsis, and shock. Basel: Marcel Dekker, New York 1988, pp 123-159.
9. Coon WW, Willis PW: Some side effects of heparin, heparinoids, and their antagonists. Clin Pharmacol Ther 7:379-398, 1966.
10. Mahadoo J, Heibert L, Jaques LB: Vascular sequestration of heparin. Thromb Res 12:79-90, 1977.
11. Blajchman MA, Young E, Ofosu FA: Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits. Ann NY Acad Sci 556:245-254, 1989.
12. Wang Singh G, Rana MW, Ba ZF, Chaudry IH: Preheparinization improves organ function following hemorrhage and resuscitation. Am J Physiol 259:R645-R650, 1990.
13. Baker SP, O'Neil LB: The injury severity score: An update. J Trauma 16:882-888, 1976.
14. Members of the American College of Chest Physicians/Society of Critical Care Medicine Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
15. Hammerson F, Hammerson E: The ultastructure of endothelial gap formation and leucocyte emigration. Prog Appl Microcirc 12:1-7, 1987.
16. Korthuis RJ, Anderson DC, Granger DN: Role of neutrophil endothelial cell adhesion in inflammatory disorders. J Crit Care 9:47-71, 1994.
17. Ma XI, Tsao PS, Viehamn GE, Lefer AM: Antibody to CD-18 exerts endothelial and cardioprotective effects on myocardial ischemia and reperfusion. J Clin Invest 88:1237-1243, 1991.
18. Pittard AJ, Hawkins WJ, Webster NR: The role of the microcirculation in the multi-organ dysfunction syndrome. Clin Intensive Care 5:186-190, 1994.
19. Hickey PR, McGowan: Adhesion molecules and inflammation: the next targets for perioperative organ protection? Anesth Analg 81:1123-1124, 1995.
20. Lobb R, Chi-Rosso G, Leone DR, et al: Expression and functional characterization of a soluble form of endothelial-leucocyte adhesion molecule 1. J Immunol 147:124-129, 1991.
21. Lo SK, Lee S, Ramos RA, et al: Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of neutrophil integrin CR3 (CD11a/ CD18, Mac-1, alpha and beta-2) on human neutrophils. J Exper Med 173:1493-1500, 1991.
22. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 147:3788-3793, 1991.
23. Chaudry IH, Ayala A: Immune consequences of hypovolemic shock and resuscitation. Current Opin Anesth 6:385-392, 1993.
24. Yamazaki M, Asakura H, Sato T, et al: Changes in plasma levels of throm bomodulin during haemodialysis. Blood Coagul Fibrinol 3:113-117, 1992.
25. Sakurabayashi I, Itou S, Ishii H: Studies on granulocyte elastase in plasma. Jap J Clin Hematol 33:1113-1118, 1985.
26. Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 24:1782-1786, 1996.
27. Sessler CN, Windsor A, Watson L, Schwartz M, Fowler AA: Soluble ICAM-1 receptor levels are increased in human septic shock. Chest 104(suppl):11S, 1993.
28. Pober JS, Gimbrone MA, Lapierre LA, et al: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and human interferon. J Immunol 137:1893-1896, 1986.
29. Redl H, Dinges HP, Buurman WA, et al: Expression of endothelial leucocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Path 139:461-466, 1991.
30. Uchiyama H, Ohtani H, Hiraishi S, Horie S, Ishii H, Kazama M: Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced disseminated intravascular coagulation and the effect of heparin. Thromb Res 65:593-604, 1992.
31. Rana MW, Singh G, Wang P, Ayaly A, Zhou M, Chaudry IH: Protective effects of pre-heparinization on microvasculature during and following hemorrhagic shock. J Trauma 32:420-426, 1992.
32. Devereux DF, Michas CA, Rice S: Heparin pretreatment suppresses norepinephrine concentrations in dogs in endotoxic shock. Clin Chem 23: 1346-1347, 1077.
33. Bazzoni G, Beltran Nunez A, Mscellani G, Bianchini P, Dejana E, Del-Maschino A: Effects of heparin, dermatan sulfate, and related oligoderivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 121:268-275, 1993.
34. Fry DE, Hanschen SR, Ratcliff DJ, Garrison RN: The effects of heparin on hemorrhagic shock. Circ Shock 13:60-61, 1984.
35. Gamble JR, Skinner MP, Berndt MC, Vadas MA: Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science 249:414-417, 1990.
36. Hack CE, Thijs LG: The ochestra of mediators in the pathogenesis of septic shock: A review. In Vincent JL (ed): Update in Intensive Care and Emergency Medicine. Vol 14. Heidelberg, New York, Tokyo: Springer, 1991, pp 232-246.
37. Aruffo A, Kolanus W, Walz G, Fredman P, Seed B: CD62/P selectin recognition of myeloid and tumor cell sulfatides. Cell 67:35-44, 1991.
38. Skinner MP, Likas CM, Burns GF, Chesterman CN, Berndt MC: GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 26:5371-5374, 1991.
39. Mulligan MS, Polley MJ, Bayer RJ, Nunn MF, Paulson JC, Ward P: Neutrophil-dependant acute lung injury. J Clin Invest 90:1600-1607, 1992.
40. Mayrovitz H, Wiedemann M, Tuma R: Factors influencing leukocyte adherence in microvessels. Thromb Haemost 38:823-830, 1987.